Pharmacokinetic Changes of Ceftazidime-Avibactam with Veno-Arterial Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Severe Renal Impairment: A Case Report. [PDF]
Infect Drug ResistShen Z, Qin H, Li Q, Mao X.
europepmc +1 more source
Effectiveness and safety of ceftazidime/avibactam versus polymyxin B in liver transplant recipients with carbapenem-resistant organism infections: a real-world cohort study. [PDF]
J Pharm Policy PractZhang W +6 more
europepmc +1 more source
Unlocking potentials: the impact of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam in combating carbapenem-resistant Enterobacter cloacae. [PDF]
Antimicrob Agents ChemotherLavoie T +5 more
europepmc +1 more source
Stability of Two Reserve Antibiotics in Elastomeric Pumps: Ceftazidime-Avibactam and Ceftolozane-Tazobactam. [PDF]
Antibiotics (Basel)Erdmann J +3 more
europepmc +1 more source
Is Ceftazidime-Avibactam become a savior for carbapenem-resistant organisms or need something more? [PDF]
J Family Med Prim CareMukhida S, Desai D.
europepmc +1 more source
A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>. [PDF]
Antimicrob Agents ChemotherArun B +6 more
europepmc +1 more source
Comparison of outcomes of KPC-producing Enterobacterales bloodstream infections treated with ceftazidime-avibactam and other conventional antibiotics: retrospective single-center study. [PDF]
Microbiol SpectrKwon K +10 more
europepmc +1 more source
Pharmacokinetics/pharmacodynamics of ceftazidime-avibactam in critically ill adult patients receiving continuous renal replacement therapy. [PDF]
Antimicrob Agents ChemotherLi C +7 more
europepmc +1 more source